Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects-Reference-Cited by-同舟云学术

Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects

Published:2019-04-08 Issue:3 Volume:68 Page:1151-1159
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Somers Charisse¹,Lewczuk Piotr²³,Sieben Anne⁴,Van Broeckhoven Christine⁵⁶,De Deyn Peter Paul¹⁴⁷,Kornhuber Johannes²,Martin Jean-Jacques⁴,Bjerke Maria¹,Engelborghs Sebastiaan¹⁷

Affiliation:

1. Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

2. Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany

3. Department of Neurodegeneration Diagnostics, Medical University of Białystok, Białystok, Poland

4. Biobank, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

5. Neurodegenerative Brain Diseases Group, Center for Molecular Neurology, VIB, Antwerp, Belgium

6. Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

7. Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference47 articles.

1. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia;Engelborghs;Neurobiol Aging,2008

2. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry;Lewczuk;World J Biol Psychiatry,2018

3. Advancing research diagnostic criteria for Alzheimer’s disease: The IWG-2 criteria;Dubois;Lancet Neurol,2014

4. A decade of cerebrospinal fluid biomarkers for Alzheimer’s disease in Belgium;Somers;J Alzheimers Dis,2016

5. Cerebrospinal fluid P-Tau181P: Biomarker for improved differential dementia diagnosis;Struyfs;Front Neurol,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of plasma candidate biomarkers of Alzheimer’s Disease;Neurologia i Neurochirurgia Polska;2024-08-28

2. Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score;Journal of Alzheimer's Disease;2023-10-24

3. Prognostischer und differenzialdiagnostischer Stellenwert der Liquordiagnostik bei neurodegenerativen Demenzerkrankungen;Der Nervenarzt;2022-06-07

4. CSF biomarkers for dementia;Practical Neurology;2022-03-17

5. Differential Expression of miR-381-3p in Alzheimer’s Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation;Neuroimmunomodulation;2021-11-08